Linked Life Data

16405435

Source:http://linkedlifedata.com/resource/pubmed/id/16405435

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-1-12
pubmed:abstractText
Technetium-99m 2-methoxyisobutylisonitrile (MIBI) imaging has been proposed as a front-line investigation to detect bone disease both before and after the treatment of myeloma. In this study, we have compared the pattern of MIBI uptake (focal and diffuse) between patients with proven myeloma and a cohort of patients without myeloma, in order to identify the uptake pattern that best correlates with disease activity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0902-4441
pubmed:author
pubmed:issnType
Print
pubmed:volume
76
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
141-6
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Focal MIBI uptake is a better indicator of active myeloma than diffuse uptake.
pubmed:affiliation
Department of Nuclear Medicine, Monash University, The Alfred Hospital, Prahran, Victoria, Australia. deenandurkar@hotmail.com
pubmed:publicationType
Journal Article